ASCO's strategic plan for cancer care in LMICs
Dr Bishal Gyawali speaks to ecancer about how the COVID-19 pandemic is affecting cancer care and evidence based medicine.
He begins by explaining that although there are many negative impacts, some changes made through necessity are having a benefit for cancer patients.
He explains that patients having as much care at home as possible and reducing low value practice are among the positive influences.
Dr Gyawali also discusses how, due to the pressure of the pandemic, the suggestion of some treatments does not follow the principles of evidence based medicine.
He hopes that we can continue the positive changes beyond the pandemic.
ASCO's strategic plan for cancer care in LMICs
Synthetic biology and precision medicine in blood and gynaecological cancers
Introducing oncology to undergraduate medical and allied health sciences students
OncoAlert Round Up for September 15-21, 2023
OncoAlert Round Up for September 8-14, 2023
Treating cancer in the heart of the Ukraine conflict
ASCO's efforts to improve global cancer care through the years
US NCI's global health initiatives at ASCO 2023
Decision making in paediatric oncology